The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias

MJ Curtis, JC Hancox, A Farkas, CL Wainwright… - Pharmacology & …, 2013 - Elsevier
The 'Lambeth Conventions' is a guidance document, written in 1987 (Walker et al., 1988),
intended to be of practical value in the investigation of experimental arrhythmias induced by …

Anti-tumoral effect of scorpion peptides: Emerging new cellular targets and signaling pathways

N Srairi-Abid, H Othman, D Aissaoui, R BenAissa - Cell calcium, 2019 - Elsevier
Scorpion toxins have been the subject of many studies exploring their pharmacological
potential. The high affinity and the overall selectivity to various types of ionic channels …

Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes

T Block, J Creech, AM da Rocha, M Marinkovic… - Scientific reports, 2020 - nature.com
The immature phenotype of human induced pluripotent stem cell derived cardiomyocytes
(hiPSC-CMs) is a major limitation to the use of these valuable cells for pre-clinical toxicity …

Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes

N Szentandrássy, K Kistamás, B Hegyi… - … -European Journal of …, 2015 - Springer
Although beat-to-beat variability (short-term variability, SV) of action potential duration (APD)
is considered as a predictor of imminent cardiac arrhythmias, the underlying mechanisms …

[HTML][HTML] Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes

MKB Jonsson, G Duker, C Tropp, B Andersson… - Stem cell …, 2010 - Elsevier
To improve proarrhythmic predictability of preclinical models, we assessed whether human
ventricular-like embryonic stem cell-derived cardiomyocytes (hESC-CMs) can be selected …

Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice

AS Farkas, S Nattell - Drugs, 2010 - Springer
Proarrhythmia, the development of new or worse arrhythmias in response to drug therapy, is
a major limitation to the development and use of new drugs. There are different types of drug …

Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk

GA Gintant - Pharmacology & therapeutics, 2008 - Elsevier
The successful development of novel drugs requires the ability to detect (and avoid)
compounds that may provoke Torsades-de-Pointes (TdeP) arrhythmia while endorsing …

Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit

I Jacobson, L Carlsson, G Duker - Journal of pharmacological and …, 2011 - Elsevier
INTRODUCTION: Accumulating evidence suggest that drug-induced QT prolongation per se
poorly predicts repolarisation-related proarrhythmia liability. We examined whether beat-by …

Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits

KE Odening, BA Jung, CN Lang, RC Lozoya, D Ziupa… - Heart Rhythm, 2013 - Elsevier
Background Enhanced dispersion of action potential duration (APD) is a major contributor to
long QT syndrome (LQTS)-related arrhythmias. Objective To investigate spatial correlations …

Dog left ventricular midmyocardial myocytes for assessment of drug‐induced delayed repolarization: short‐term variability and proarrhythmic potential

N Abi‐Gerges, JP Valentin… - British journal of …, 2010 - Wiley Online Library
Background and purpose: Evaluation of the potential for delayed ventricular repolarization
and proarrhythmia by new drugs is essential. We investigated if dog left ventricular …